Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000365

Drug Information
NameDihydrotachysterol    
SynonymsDht(sub 2); (3E)-3-[(2E)-2-[1-[(E)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol; dihydrotachysterol; C06957; 9,10-Secoergosta-5,7,22-trien-3-ol, (3.beta.,5E,7E,10.alpha.,22E)-; LS-148512; MolPort-003-941-198; AC1NQXW4; Dygratyl; D9257_SIGMA; EINECS 200-672-7; Dihydrotachysterol(sub 2); NCGC00166147-01; CHEBI:4591; Dihidrotaquisterol; Dichystrolum; Diidrotachisterolo [DCIT]; ST075187; Parterol; Dihydrotachysterolum [INN-Latin]; Anti-tetany substance 10; CID5702045; HSDB 3314; IDI1_000869; CID5353584; 67-96-9; NCGC00166147-02; 9,10-Secoergosta-5,7,22-trien-3beta-ol; HMS502L11; Dihydrotachysterolum; Tachysterol2, dihydro-; Antitanil; 9,10-Secoergosta-5,7,22-trien-3-ol, (3beta,5E,7E,10alpha,22E)-; (3Z)-3-[(2E)-2-[1-[(E)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol; Dihydral; Tachyrol; D9257_FLUKA; Calcamine; Dht Intensol; (3S,5E,7E,10S,22E)-9,10-secoergosta-5,7,22-trien-3-ol; C28H46O; AC1NSJXZ; CID5281010; Diidrotachisterolo; (1S,3E,4S)-3-[(2E)-2-[(3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol; Tachysterol, dihydro-; DB01070; (1S,3E,4S)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol; AC1NWALO; Dihidrotaquisterol [INN-Spanish]; DHT2; CID5311071; Hytakerol; Dihydrotachysterol [INN:BAN:JAN]; Tachystin; AT 10; AC1NS4C8; LMST03010056; A.T. 10    
IndicationHypocalcemia and hypoparathyroidismApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntihypoparathyroid Agents    
CAS NumberCAS 67-96-9
FormularC28H46O    
PubChem Compound IDCID 5702045.    
PubChem Substance IDSID 8149307.    
ChEBI4591;    
SuperDrug ATC IDA11CC02;    
SuperDrug CAS ID000067969;    
TargetVitamin D receptorAntagonist[2][3]
Ref 1News and Information about Scopolamine. 2009 To Reference
Ref 2In vivo metabolism of the vitamin D analog, dihydrotachysterol. Evidence for formation of 1 alpha,25- and 1 beta,25-dihydroxy-dihydrotachysterol metabolites and studies of their biological activity. J Biol Chem. 1993 Jan 5;268(1):282-92. To Reference
Ref 3Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1689S-96S. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543